Connection

Robert Wilson to 11-beta-Hydroxysteroid Dehydrogenase Type 2

This is a "connection" page, showing publications Robert Wilson has written about 11-beta-Hydroxysteroid Dehydrogenase Type 2.
  1. In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess. J Clin Endocrinol Metab. 2004 May; 89(5):2024-7.
    View in: PubMed
    Score: 0.228
  2. Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11?-hydroxysteroid dehydrogenase type 2 deficiency. Proc Natl Acad Sci U S A. 2017 12 26; 114(52):E11248-E11256.
    View in: PubMed
    Score: 0.146
  3. A novel mutation in HSD11B2 causes apparent mineralocorticoid excess in an Omani kindred. Ann N Y Acad Sci. 2016 07; 1376(1):65-71.
    View in: PubMed
    Score: 0.134
  4. Apparent mineralocorticoid excess. Trends Endocrinol Metab. 2001 Apr; 12(3):104-11.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.